grepafloxacin has been researched along with Bacterial Infections in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (86.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, JM; Cook, PJ; Honeybourne, D; Moudgil, H; Wise, R | 1 |
| Imada, T; Mukai, F; Ohguro, K; Ohmori, K; Tamaoka, H; Wakebe, H; Yabuuchi, Y; Yoneda, H | 1 |
| Goldstein, EJ | 1 |
| Balfour, JA; Wagstaff, AJ | 1 |
| Andrews, JM; Wise, R | 1 |
| Heisig, P; Wiedemann, B | 1 |
| Amantea, MA; Chodosh, S; Collins, DA; Forrest, A; Schentag, JJ | 1 |
| Breisch, S; Cranfield, R; Langan, CE; Pettit, R | 1 |
| Schwabe, R; Stahlmann, R | 1 |
| Norrby, SR | 1 |
| Bagby, B; Bettis, R; Collins, JJ; DeAbate, CA; Fleming, H; Giguere, G; Munk, ZM; Munn, NJ; Riffer, E | 1 |
| Hooper, DC | 2 |
| Goto, S; Imada, T; Miyazaki, S; Nishida, M; Yamaguchi, K | 1 |
8 review(s) available for grepafloxacin and Bacterial Infections
| Article | Year |
|---|---|
Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Safety; Syndrome | 1996 |
Grepafloxacin.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Multicenter Studies as Topic; Piperazines; Quinolones; Randomized Controlled Trials as Topic | 1997 |
Antibacterial activity of grepafloxacin.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Piperazines; Quinolones | 1997 |
Safety profile of grepafloxacin compared with other fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation; Fluoroquinolones; Humans; Piperazines; Quinolones | 1997 |
Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Piperazines; Quinolones; Respiratory Tract Infections | 1997 |
New fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Piperazines; Respiratory Tract Infections | 1999 |
New uses for new and old quinolones and the challenge of resistance.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sensitivity and Specificity; Sexually Transmitted Diseases; Urinary Tract Infections | 2000 |
The fluoroquinolones after ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial; Skin Diseases, Bacterial; Urinary Tract Infections | 2000 |
3 trial(s) available for grepafloxacin and Bacterial Infections
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Male; Middle Aged; Models, Biological; Piperazines; Quinolones; Time Factors | 1997 |
Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Hematologic Tests; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Piperazines; Quinolones; Treatment Outcome | 1997 |
Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Quinolones | 1999 |
4 other study(ies) available for grepafloxacin and Bacterial Infections
| Article | Year |
|---|---|
Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchoalveolar Lavage Fluid; Female; Fluoroquinolones; Humans; Lung; Macrophages, Alveolar; Male; Middle Aged; Mucous Membrane; Piperazines; Quinolones; Tissue Distribution | 1995 |
Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Piperazines; Pneumonia; Quinolones; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections | 1994 |
The activity of grepafloxacin against respiratory pathogens in the UK.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; England; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Penicillins; Piperazines; Quinolones; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 1997 |
In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bacterial Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Piperazines; Quinolones; Tissue Distribution | 1992 |